HMGCR and hyperlipidemia: Statins are the mostly used drugs for hyperlipidemia treatment, by competitive inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, an enzyme involved in the rate-limiting step of cholesterol biosynthesis (Murphy et al., 2020).